POORLY DIFFERENTIATED THYROID CARCINOMA

POORLY DIFFERENTIATED THYROID CARCINOMA was reported 10 times

POORLY DIFFERENTIATED THYROID CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
1 Kinase Inhibitor [EPC] 7 0.0000
2 Microtubule Inhibitor [EPC] 2 0.0000
3 RANK Ligand Inhibitor [EPC] 2 0.0000
4 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
6 GLP-1 Receptor Agonist [EPC] 1 0.0000
7 Proton Pump Inhibitor [EPC] 1 0.0000